WilliamBrianDaltonMDPhD

Oncology • Baltimore, MD

Hematologic Oncology

Physician

Join to view full profile

Dr. Dalton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dalton's full profile

Already have an account?

Office
1800 Orleans Street
Baltimore, MD 21287
Phone+1 410-955-5000

Fax+1 410-955-5001

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2013 - 2016
Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
Emory University School of MedicineClass of 2010

Certifications & Licensure

MD State Medical License 2013 - 2026

Publications & Presentations

PubMed

Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1-mutant cholangiocarcinoma.
Daniel J Zabransky, Emma Kartalia, Jae W Lee, James M Leatherman, Soren Charmsaz
Hepatology. 2024-12-03
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts.
In Young Choi, Jonathan P Ling, Jian Zhang, Eric Helmenstine, Wencke Walter
Blood Advances. 2024-08-13
1 citations
Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a subset of myelodysplastic/ myeloproliferative neoplasm with neutrophilia.
Tania Jain, Alisha D Ware, William Brian Dalton, Sergiu Pasca, Hua-Ling Tsai
Leukemia Research. 2023-08-01

Abstracts/Posters

Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume Leukapheresis
William Brian Dalton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate CuresMay 9th, 2021